Publication
Article
OTC Guide
Author(s):
A new message by the Public Access to SunScreens (PASS) Coalition—comprised of public health organizations, physician groups, sunscreen manufacturers, and citizens—emphasizes the importance of sunscreen in reducing the risk of melanoma, other skin cancers, and premature aging.1
A new message by the Public Access to SunScreens (PASS) Coalition—comprised of public health organizations, physician groups, sunscreen manufacturers, and citizens—emphasizes the importance of sunscreen in reducing the risk of melanoma, other skin cancers, and premature aging.1
A warning such as this is critical, according to the coalition. In 2019, more than 192,000 Americans will be diagnosed with melanoma and over 7,200 Americans will die from the disease. This is a 7.7% increase from 2018.1
Pharmacists can counsel patients on the best way to reduce the risk of this disease: having a daily regimen of sunscreen, wearing UV protective clothing, sunglasses, and limiting time in direct sunlight.
There is a lot of misinformation about sunscreen, according to Melanoma Research Alliance Chief Executive Officer and President Michael Kaplan.1
“Despite the hype, experts agree that everyone should be diligent about applying and reapplying sunscreen throughout the day to make sure they are protected. The best sunscreen continues to be the one you’ll wear every day,” he said in a statement.1
Consumer confidence in sunscreen safety has been muddled with recent attention focused on a new FDA-proposed rule that would update labeling requirements and the list of approved sunscreens. However, as the FDA moves through this process and retests existing ingredients, the guidelines remain: choose a sunscreen that is broad spectrum, has at least a sun protection factor of 30, and is water-resistant.1
The Skin Cancer Foundation offered additional guidelines for skin cancer prevention that can be shared with patients2:
For more OTC recommendations from pharmacists, visit OTCguide.net.
References